IP Library › Granted Patent US 10,363,355
Granted Patent B2
US 10,363,355 · App. 15/693,799 · Granted Jul 30, 2019

System and method for platelet removal during mononuclear cell collection

Inventors: Jonathan W. Prendergast (Palatine, IL); Lan T. Nguyen (Vernon Hills, IL); Katherine N. Radwanski (Highland Park, IL)
Assignee: Fenwal, Inc.
A61M1/3693A61M1/0209A61M1/3496A61M1/361A61M1/38A61M1/385B01D63/16A61M1/3672A61M2202/0427A61M2202/0439A61M2202/0443
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,363,355
App. No.
15/693,799
Granted
Jul 30, 2019
Kind
B2
Abstract

A method of collecting mononuclear cells, comprising separating whole blood into cellular components and platelets suspended in plasma, separating the platelets suspended in plasma into platelet concentrate and platelet-poor plasma, combining the cellular components with the platelet-poor plasma to form a first mixture, and separating the first mixture into mononuclear cells and at least one component.

Claims (39)

1. A method of collecting mononuclear cells, comprising:

separating whole blood into cellular components and platelet-rich plasma;

separating the platelet-rich plasma into platelet concentrate and platelet-poor plasma;

combining the cellular components with the platelet-poor plasma to form a first mixture; and

separating the first mixture into mononuclear cells and at least one component.

2. The method of claim 1 , wherein the platelet-poor plasma contains fewer platelets than does the platelet-rich plasma.

3. The method of claim 1 , wherein the whole blood is separated into cellular components and platelet-rich plasma by a centrifugal separator.

4. The method of claim 3 , wherein the whole blood, the platelet-rich plasma and the first mixture are separated within a compartment of a separation chamber, with the cellular components and the platelet-rich plasma being directed to separate locations until separation of the whole blood is complete.

5. The method of claim 4 , wherein said separating whole blood into cellular components and platelet-rich plasma and said separating the first mixture into mononuclear cells and at least one component take place substantially in series.

6. The method of claim 3 , wherein

the whole blood is separated within a first compartment of a separation chamber, with the platelet-rich plasma being directed to a second compartment of the separation chamber, and with the platelet-rich plasma being separated into platelet concentrate and platelet-poor plasma in the second compartment; and

the first mixture is directed to and separated within the first or second compartment of the separation chamber.

7. The method of claim 6 , wherein said separating whole blood into cellular components and platelet-rich plasma and said separating the platelet-rich plasma into platelet concentrate and platelet-poor plasma take place substantially at the same time.

8. The method of claim 6 , further comprising stopping the directing of the platelet-rich plasma into the second compartment from the first compartment when an optical sensor disposed downstream of the first compartment detects that fluid leaving the first compartment has adequate clarity.

9. The method of claim 1 , wherein the whole blood is separated into cellular components and platelet-rich plasma by a spinning membrane separator.

10. The method of claim 1 , wherein said separating whole blood into cellular components and platelet-rich plasma and said separating the platelet-rich plasma into platelet concentrate and platelet-poor plasma take place substantially at the same time.

11. An automated system of collecting mononuclear cells, comprising:

a separator including a controller; and

a disposable fluid circuit configured to work in association with the separator, wherein the controller is configured to control the separator to

separate whole blood in the disposable fluid circuit into cellular components and platelet-rich plasma,

separate the platelet-rich plasma into platelet-concentrate and platelet-poor plasma,

combine the cellular components with the platelet-poor plasma to form a first mixture, and

separate the first mixture into mononuclear cells and at least one component.

12. The system of claim 11 , wherein the separator separating the whole blood into cellular components and platelet-rich plasma is a centrifugal separator.

13. The system of claim 11 , wherein the separator separating the whole blood into cellular components and platelet-rich plasma is a spinning membrane separator.

14. The system of claim 11 , wherein the whole blood is separated into cellular components and platelet-rich plasma, and the platelet-rich plasma is separated into platelet concentrate and platelet-poor plasma at substantially at the same time.

15. The system of claim 11 , wherein the platelet-rich plasma is separated into platelet concentrate and platelet-poor plasma, and the first mixture is separated into mononuclear cells and the at least one component substantially in series.

16. The system of claim 12 , wherein

the disposable fluid circuit includes a separation chamber having a compartment, and

the whole blood, platelet-rich plasma, and first mixture are separated in the compartment of the separation chamber.

17. The system of claim 12 , wherein

the disposable fluid circuit includes a separation chamber having a first compartment and a second compartment,

the whole blood is separated in the first compartment, and

the platelet-rich plasma is separated in the second compartment.

18. The system of claim 17 , wherein the first mixture is separated in the first compartment.

19. The system of claim 17 , wherein the first mixture is separated in the second compartment.

20. The system of claim 17 , wherein

the separator further includes an optical sensor configured to monitor a portion of the disposable fluid circuit downstream of the first compartment, and

the controller is configured to stop directing platelet-rich plasma to the second compartment when the optical sensor detects that fluid leaving the first compartment has adequate clarity.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2017
From: PRENDERGAST, JONATHAN W.; NGUYEN, LAN T.; RADWANSKI, KATHERINE N.
To: FENWAL, INC.
Reel/Frame 043471/0422 →
Continuity (2)
Provisional Application 62397434 · Sep 21, 2016
Related Publication 20180078699A1 · Mar 22, 2018
Cited By (1)
US 12,558,469